annual D&A:
$69.54M-$38.13M(-35.41%)Summary
- As of today (June 22, 2025), GDRX annual depreciation & amortization is $69.54 million, with the most recent change of -$38.13 million (-35.41%) on December 31, 2024.
- During the last 3 years, GDRX annual D&A has risen by +$35.00 million (+101.33%).
- GDRX annual D&A is now -35.41% below its all-time high of $107.67 million, reached on December 31, 2023.
Performance
GDRX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$20.91M+$1.82M(+9.51%)Summary
- As of today (June 22, 2025), GDRX quarterly depreciation & amortization is $20.91 million, with the most recent change of +$1.82 million (+9.51%) on March 31, 2025.
- Over the past year, GDRX quarterly D&A has increased by +$4.97 million (+31.18%).
- GDRX quarterly D&A is now -52.05% below its all-time high of $43.61 million, reached on December 31, 2023.
Performance
GDRX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$74.51M+$4.97M(+7.15%)Summary
- As of today (June 22, 2025), GDRX TTM depreciation & amortization is $74.51 million, with the most recent change of +$4.97 million (+7.15%) on March 31, 2025.
- Over the past year, GDRX TTM D&A has dropped by -$34.16 million (-31.44%).
- GDRX TTM D&A is now -31.98% below its all-time high of $109.54 million, reached on June 30, 2024.
Performance
GDRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GDRX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.4% | +31.2% | -31.4% |
| 3 y3 years | +101.3% | +83.9% | +83.7% |
| 5 y5 years | +412.3% | +381.3% | +1614.8% |
GDRX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.4% | +101.3% | -52.0% | +83.9% | -32.0% | +83.7% |
| 5 y | 5-year | -35.4% | +412.3% | -52.0% | +381.3% | -32.0% | +1614.8% |
| alltime | all time | -35.4% | +609.1% | -52.0% | +381.3% | -32.0% | +1614.8% |
GDRX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $20.91M(+9.5%) | $74.51M(+7.1%) |
| Dec 2024 | $69.54M(-35.4%) | $19.10M(+8.9%) | $69.54M(-26.1%) |
| Sep 2024 | - | $17.54M(+3.4%) | $94.05M(-14.1%) |
| Jun 2024 | - | $16.96M(+6.4%) | $109.54M(+0.8%) |
| Mar 2024 | - | $15.94M(-63.4%) | $108.67M(+0.9%) |
| Dec 2023 | $107.67M(+98.7%) | $43.61M(+32.0%) | $107.67M(+35.3%) |
| Sep 2023 | - | $33.02M(+105.2%) | $79.59M(+31.5%) |
| Jun 2023 | - | $16.10M(+7.8%) | $60.52M(+4.8%) |
| Mar 2023 | - | $14.94M(-3.8%) | $57.74M(+6.6%) |
| Dec 2022 | $54.18M | $15.53M(+11.3%) | $54.18M(+9.9%) |
| Sep 2022 | - | $13.95M(+4.8%) | $49.29M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $13.32M(+17.1%) | $45.50M(+12.2%) |
| Mar 2022 | - | $11.37M(+6.8%) | $40.55M(+17.4%) |
| Dec 2021 | $34.54M(+87.4%) | $10.65M(+4.8%) | $34.54M(+22.1%) |
| Sep 2021 | - | $10.16M(+21.4%) | $28.30M(+21.5%) |
| Jun 2021 | - | $8.37M(+56.1%) | $23.29M(+19.8%) |
| Mar 2021 | - | $5.36M(+21.7%) | $19.45M(+5.5%) |
| Dec 2020 | $18.43M(+35.8%) | $4.40M(-14.7%) | $18.43M(+31.4%) |
| Sep 2020 | - | $5.16M(+14.1%) | $14.03M(+58.2%) |
| Jun 2020 | - | $4.52M(+4.1%) | $8.87M(+104.1%) |
| Mar 2020 | - | $4.34M | $4.34M |
| Dec 2019 | $13.57M(+38.4%) | - | - |
| Dec 2018 | $9.81M | - | - |
FAQ
- What is GoodRx Holdings annual depreciation & amortization?
- What is the all time high annual D&A for GoodRx Holdings?
- What is GoodRx Holdings annual D&A year-on-year change?
- What is GoodRx Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GoodRx Holdings?
- What is GoodRx Holdings quarterly D&A year-on-year change?
- What is GoodRx Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for GoodRx Holdings?
- What is GoodRx Holdings TTM D&A year-on-year change?
What is GoodRx Holdings annual depreciation & amortization?
The current annual D&A of GDRX is $69.54M
What is the all time high annual D&A for GoodRx Holdings?
GoodRx Holdings all-time high annual depreciation & amortization is $107.67M
What is GoodRx Holdings annual D&A year-on-year change?
Over the past year, GDRX annual depreciation & amortization has changed by -$38.13M (-35.41%)
What is GoodRx Holdings quarterly depreciation & amortization?
The current quarterly D&A of GDRX is $20.91M
What is the all time high quarterly D&A for GoodRx Holdings?
GoodRx Holdings all-time high quarterly depreciation & amortization is $43.61M
What is GoodRx Holdings quarterly D&A year-on-year change?
Over the past year, GDRX quarterly depreciation & amortization has changed by +$4.97M (+31.18%)
What is GoodRx Holdings TTM depreciation & amortization?
The current TTM D&A of GDRX is $74.51M
What is the all time high TTM D&A for GoodRx Holdings?
GoodRx Holdings all-time high TTM depreciation & amortization is $109.54M
What is GoodRx Holdings TTM D&A year-on-year change?
Over the past year, GDRX TTM depreciation & amortization has changed by -$34.16M (-31.44%)